Bone Densitometer Market worth $378 million by 2027 – Exclusive Report by MarketsandMarkets™
Chicago, July 27, 2022 (GLOBE NEWSWIRE) -- Bone Densitometer Market size is projected to reach USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the forecast period, according to a new report by MarketsandMarkets™. The Factors such as the increasing prevalence of osteoporosis and the growing geriatric population are expected to drive the growth of this market during the forecast period. However, the high cost of bone densitometers is expected to restrain the growth of this market during the forecast period.
Browse in-depth TOC on “Bone Densitometer Market”
147 – Tables
26 – Figures
154 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15369222
By Technology, the Axial Bone Densitometry segment is expected to account for the largest share of the Bone Densitometer market
The axial bone densitometry segment accounted for the largest share the bone densitometers market in 2021. The large share of this segment can be attributed to the advantages of DEXA scanners over peripheral bone densitometers. Moreover, the results obtained from DEXA scanners can be interpreted using WHO scores for greater accuracy.
By Application, the Osteoporosis & Osteopenia Diagnosis segment is expected to account for the largest share of the Bone Densitometers market
The osteoporosis & osteopenia diagnosis accounted for the largest share of the global market in 2021. The large share of this segment can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.
By End User, the Hospitals & Specialty Clinics segment is expected to account for the largest share of the Bone Densitometer market
The hospitals & specialty clinics segment accounted for the largest share of the global bone densitometers market in 2021. The large share of this segment can be attributed to the higher preference of patients for hospital-based treatment of diseases such as cystic fibrosis, chronic kidney disease, and osteoporosis.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=15369222
North America dominated this market with the largest share in 2021
In 2021, North America dominated this market with the largest share. This can be attributed to the high consumer awareness, rising healthcare expenditure, the increasing prevalence of osteoporosis, and the presence of key market players in the region.
Some of the prominent players operating in the global bone densitometers market are GE Healthcare (US), Hologic, Inc. (US), OSI Systems, Inc. (US), Diagnostic Medical Systems Group (France), Swissray Global Healthcare Holding, Ltd. (Taiwan), BeamMed, Ltd. (Israel), Echolight S.P.A (Italy), Scanflex Healthcare AB (Sweden), Medonica Co., Ltd. (South Korea), Eurotec Systems S.r.l (Italy), AMPall Co., Ltd. (South Korea), L’acn L’accessorio Nucleare S.R.L (Italy), Shenzhen XRAY Electric Co., Ltd. (China), YOZMA BMTech Co., Ltd. (South Korea), Nanoomtech Co., Ltd. (South Korea), Osteosys Corporation (South Korea), FURUNO Electric Co., Ltd. (Japan), Xianyang Kanrota Digital Ultrasound System, Co., Ltd. (China), XinGaoYi Co., Ltd. (China), Anjue Medical Equipment (China), Guangzhou Medsinglong Medical Equipment Co., Ltd. (China), Trivitron Healthcare (India), OsCare Medical Oy (Finland), CyberLogic, Inc. (US), and Nanjing Kejin Industrial Co., Ltd. (China).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=15369222
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2025
Bone Growth Stimulator Market by Product (Device (Implant, External), Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delayed Union, Non-union Bone Fracture, Maxillofacial Surgery), Care Setting (Hospital, Homecare) (2022 - 2026)
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com
